MFDS
- Marketing authorisation holder: COHERUS BIOSCIENCES INC
- Status: likely_approved
🇰🇷 Loqtorzi in South Korea
Loqtorzi (TORIPALIMAB) regulatory status in South Korea.
Marketing authorisation
Loqtorzi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Loqtorzi approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Loqtorzi in South Korea?
COHERUS BIOSCIENCES INC holds the South Korean marketing authorisation.